# LEVO-T

NDC: 55466-112
Generic name: Levothyroxine Sodium
Labeler / Manufacturer: Neolpharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20151029

FDA application: NDA021342

## Active ingredients

- LEVOTHYROXINE SODIUM: 150 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55466-112"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55466-112
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2085385a-7fe4-5bfe-e054-00144ff88e88